188
Participants
Start Date
December 14, 2021
Primary Completion Date
March 31, 2028
Study Completion Date
April 30, 2028
PDS Implant With Ranibizumab 100 mg/ml
Ranibizumab 100 mg/mL will be delivered via PDS
LUCENTIS (Ranibizumab Injection)
Ranibizumab (0.5 mg intravitreal \[IVT\] injections of 10 mg/mL formulation) will be used in the study eye as supplemental treatment. If a participant discontinues study treatment, he/she may start receiving IVT ranibizumab injections in the study eye, per investigator's discretion.
RECRUITING
Erie Retina Research, Erie
RECRUITING
Cumberland Valley Retina Consultants PC, Hagerstown
WITHDRAWN
Palmetto Retina Center, Florence
RECRUITING
Cleveland Clinic Foundation, Cleveland
RECRUITING
Associated Retinal Consultants PC, Royal Oak
WITHDRAWN
Wolfe Eye Clinic, West Des Moines
RECRUITING
Fargo Retina Consultants, Fargo
RECRUITING
Tulsa Retina Consultants, Tulsa
RECRUITING
Retina Consultants of Texas, Bellaire
RECRUITING
Retina Consultants of Texas, Schertz
COMPLETED
Southwest Retina Consultants, Durango
RECRUITING
Retina Associates of Southern California, Huntington Beach
RECRUITING
California Retina Consultants, Bakersfield
RECRUITING
Spokane Eye Clinical Research, Spokane
RECRUITING
Barnet Dulaney Perkins Eye Center, Mesa
RECRUITING
California Eye Specialists Medical group Inc., Pasadena
RECRUITING
Retinal Consultants Med Group, Sacramento
RECRUITING
University of California San Francisco, San Francisco
RECRUITING
Orange County Retina Med Group, Santa Ana
RECRUITING
Macula Retina Vitreous Research Institute, Torrance
RECRUITING
Advanced Vision Research Institute, Longmont
WITHDRAWN
Retina Group of New England, Waterford
RECRUITING
Retina Specialty Institute, Pensacola
WITHDRAWN
Ft Lauderdale Eye Institute, Plantation
RECRUITING
Retina Vitreous Associates of Florida, St. Petersburg
RECRUITING
Southeast Retina Center, Augusta
RECRUITING
University Retina and Macula Associates, PC, Lemont
WITHDRAWN
Retina Associates of Kentucky, Lexington
RECRUITING
Maine Eye Center, Portland
RECRUITING
The Retina Care Center, Baltimore
RECRUITING
Wilmer Eye Institute Johns Hopkins University, Baltimore
WITHDRAWN
Retina Group of Washington, Chevy Chase
RECRUITING
VitreoRetinal Surgery, PLLC., Minneapolis
COMPLETED
Midwest Vision Research Foundation, Chesterfield
RECRUITING
Sierra Eye Associates, Reno
RECRUITING
Envision Ocular, LLC, Bloomfield
RECRUITING
Seeta Eye Centers, Poughkeepsie
WITHDRAWN
Western Carolina Retinal Associate PA, Asheville
RECRUITING
Duke Eye Center, Durham
RECRUITING
Cincinnati Eye Institute, Blue Ash
WITHDRAWN
Mid Atlantic Retina, Philadelphia
WITHDRAWN
Palmetto Retina Center, LLC, West Columbia
RECRUITING
Charles Retina Institute, Germantown
RECRUITING
Tennessee Retina PC, Nashville
RECRUITING
Panhandle Eye Group LLP Southwest Retina Specialists, Amarillo
WITHDRAWN
Austin Retina Associates, Austin
RECRUITING
Retina Associates of Utah, PLLC, Salt Lake City
RECRUITING
Piedmont Eye Center, Lynchburg
RECRUITING
Wagner Kapoor Institute, Norfolk
WITHDRAWN
Retina Institute of Virginia, Richmond
Lead Sponsor
Genentech, Inc.
INDUSTRY